A new trading day began on Monday, with Cellebrite DI Ltd (NASDAQ: CLBT) stock price down -6.89% from the previous day of trading, before settling in for the closing price of $21.35. CLBT’s price has ranged from $7.91 to $21.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Technology Sector giant was 18.79%. Meanwhile, its annual earnings per share averaged -218.60%. With a float of $86.02 million, this company’s outstanding shares have now reached $208.08 million.
Let’s determine the extent of company efficiency that accounts for 1008 employees. In terms of profitability, gross margin is 84.45%, operating margin of 14.59%, and the pretax margin is -80.02%.
Cellebrite DI Ltd (CLBT) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Software – Infrastructure Industry. The insider ownership of Cellebrite DI Ltd is 58.66%, while institutional ownership is 38.75%. The most recent insider transaction that took place on Dec 09 ’24, was worth 713,061. Before that another transaction happened on Nov 29 ’24, when Company’s Director proposed sale 10,422 for $20.26, making the entire transaction worth $211,161.
Cellebrite DI Ltd (CLBT) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -218.60% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
Here are Cellebrite DI Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.74. Likewise, its price to free cash flow for the trailing twelve months is 40.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.26 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Looking closely at Cellebrite DI Ltd (NASDAQ: CLBT), its last 5-days average volume was 1.2 million, which is a jump from its year-to-date volume of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 62.41%. Additionally, its Average True Range was 0.75.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 81.26%, which indicates a significant increase from 58.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.87% in the past 14 days, which was higher than the 39.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.61, while its 200-day Moving Average is $14.24. However, in the short run, Cellebrite DI Ltd’s stock first resistance to watch stands at $20.85. Second resistance stands at $21.81. The third major resistance level sits at $22.33. If the price goes on to break the first support level at $19.37, it is likely to go to the next support level at $18.85. Should the price break the second support level, the third support level stands at $17.89.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
With a market capitalization of 4.14 billion, the company has a total of 205,932K Shares Outstanding. Currently, annual sales are 325,110 K while annual income is -81,100 K. The company’s previous quarter sales were 106,860 K while its latest quarter income was -207,090 K.
